Microbiology SpectrumMicrobiologyPeer-reviewed journal article
First versatile reverse genetics system for feline coronavirus
Izumi KidaiD, Tomokazu TamuraiD, Yudai KurodaiD, Takasuke FukuharaiD, Ken MaedaiD, Keita MatsunoiD
- Citations
- 4
- FWCI
- 2.63
- Field percentile
- top 13%
Abstract
Feline infectious peritonitis (FIP) is a fatal disease caused by feline coronavirus (FCoV). Although multiple gene mutations in FCoV likely account for FIP pathogenesis, molecular studies for FCoV have been limited due to the lack of a suitable reverse genetics system. In the present study, we established a rapid PCR-based system to generate recombinant FCoV using the circular polymerase extension reaction (CPER) method for both serotype 1 and 2 viruses. Recombinant FCoV was successfully rescued at sufficient titers to propagate the progeny viruses with high sequence accuracy. The growth kinetics of recombinant FCoV were comparable to those of the parental viruses. We successfully generated recombinants harboring spike gene from a different FCoV strain or a reporter HiBiT-tag using the CPER method. The chimeric virus demonstrated similar characteristics with the parental virus of S gene. The reporter tag stably expressed after five serial passages in the susceptible cells, and the reporter virus could be applied to evaluate the sensitivity of antiviral inhibitors using the luciferase assay system to detect HiBiT tag. Taken together, our versatile reverse genetics system for FCoV shown herein is a robust tool to characterize viral genes even without virus isolation and to investigate the molecular mechanisms of the proliferation and pathogenicity of FCoV. ImportanceFeline infectious peritonitis is a highly fatal disease in cats caused by feline coronavirus variants that can infect systemically. Because of a lack of versatile toolbox of manipulating the feline coronavirus genome, an efficient method is urgently needed for studying virus proteins responsible for the severe disease. Herein, we established a rapid reverse genetics system for the virus and demonstrated the capability of the recombinant viruses to be introduced desired modifications or reporter genes without any negative impacts on virus characteristics in cell culture. Recombinant viruses are also useful to evaluate antiviral efficacy. Overall, our system can be a promising tool to reveal the molecular mechanisms of viral life cycle of feline coronavirus and disease progression of feline infectious peritonitis.
- organism: fungi (other)
- research focus: host-pathogen & immune response
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fatal consequences of feline coronavirus infection are associated with virus persistence and a distinct adaptive immune repertoire
Thomas K. Hiron, Sara Falcone, … Lucy J. Davison·bioRxiv·Oct 2, 2025
- Emergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
C. Atippa, A. S. Warr, … C. Tait-Burkard·bioRxiv·Nov 8, 2023
- A rational approach to identifying effective combined anticoronaviral therapies against feline coronavirus
S.E. Cook, H. Vogel, … B. G. Murphy·bioRxiv·Jul 9, 2020
- Molecular detection using hybridization capture and next-generation sequencing reveals cross-species transmission of feline coronavirus type-1 between a domestic cat and a captive wild felid
X. A. Olarte-Castillo, L. B. Goodman, G. R. Whittaker·bioRxiv·Jan 2, 2024
- Detection of Feline Coronavirus RNA in Cats with Feline Infectious Peritonitis and their Housemates
Phoenix M. Shepherd, Amy Elbe, … Robert N. Kirchdoerfer·VirusesPeer-reviewed·Jul 4, 2025
- Feline calicivirus encoding NanoLuc luciferase as a tool for assessing antibody neutralisation and antivirals
Hágár Sasvári, Kelsey Urquhart, … Lee Sherry·bioRxiv·Aug 20, 2026